Premia Spine News
7 articles
growth-positive
New back surgery aims to prevent future problems
A new type of back surgery called the TOPS system, developed by Premia Spine, is being tested in clinical trials. The goal is to improve the standard spinal fusion surgery by allowing more movement and reducing the likelihood of needing further surgery in the long term. The TOPS system is designed for patients with degenerative spondylolisthesis, where the vertebral bodies are shifted and compress the nerves. Traditional fusions lock vertebrae together, limiting movement and potentially leading to breakdown in other areas of the spine. The new device aims to keep pressure off areas above and below the fused segment. The results so far are promising, and if proven successful, the TOPS system could become the standard operation.
Customers
growth-positive
Premia Spine Features TOPS™ System and ProMIS™ Fixation System at ISASS Cadaver Lab - Ortho Spine News
Premia Spine, Ltd. will sponsor a hands-on cadaver lab for surgeons to try out their ProMIS Fixation System and TOPS System. The event will be the first time surgeons in North America have the opportunity to use both technologies in an open cadaver lab setting. The company is also offering US surgeons the chance to join their US IDE study. The study will enroll 330 subjects and compare the TOPS System to lumbar fusion. Premia Spine licensed the TOPS System technology in 2011 and has invested over $100 million in its development.
PartnersExpand
growth-positive
Premia Spine Launches TOPS IDE Study
Premia Spine, Ltd. has launched its FDA pivotal study of the TOPS System, a posterior arthroplasty device for degenerative grade I spondylolisthesis and spinal stenosis. The first surgery was performed in Pennsylvania. The company has been in commercial use in Europe for over five years. The IDE study will take place in 30 institutions and enroll 330 subjects. Premia Spine CEO Ron Sacher expressed excitement about providing U.S. patients with access to the device. The company has approval for 30 sites and is actively recruiting surgeons to join the study.
CustomersInvestment
growth-positive
Premia Spine Launches ProMIS™ Fixation System
Premia Spine has announced the launch of the ProMIS Fixation System, a spinal implant solution, at the International Society for the Advancement of Spine Surgery Meeting. The system offers multiple screw placement techniques in one instrument kit, allowing surgeons to switch techniques intraoperatively. The system also includes a unique pedicle screw with a patented surface treatment that promotes bony ingrowth. Premia Spine was founded in 2011 and has invested nearly $70 million in the development and commercialization of the ProMIS System.
Partners
growth-positive
Spine surgery co Premia Spine raising $10m
Premia Spine, an orthopedics company, has raised $7 million out of a $10 million financing round from new and current investors. The company develops and sells artificial lumbar plates for the spine. It has NIS 5-8 million in sales after two years on the market. Premia Spine was previously called Impliant and was acquired by CEO Ron Sacher. The company plans to use the funding to conduct a larger clinical trial in the US and expand its business in Europe and Asia.
InvestmentAcquisitionExpand
growth-positive
Israeli Company's Futuristic Back Implant Can Repair Damaged Spines
Premia Spine, an Israeli company, has developed a revolutionary spinal implant called the TOPS (Total Posterior Solution) system. This system offers an alternative treatment for patients who have been prescribed spinal fusion operations. The TOPS system recreates the natural motions of the back, giving patients a greater range of motion and a faster recovery. The company has been distributing a smaller version of the product in Europe and plans to double the number of centers within the next year. In the US, the TOPS system is finishing up three years of follow-up data collection to present to the FDA. Premia Spine hopes to be approved by the FDA within the next four to five years. The company has already received firm commitments from private investors for financing.
CustomersInvestment
growth-positive
New implant is alternative to spinal fusion
Israeli company Premia Spine offers a unique solution for spinal stenosis with its TOPS System, which aims to revolutionize the spinal implant market. The system allows for joint replacement rather than fusion, providing normal mobility and protecting adjacent levels of the spine. Already approved in the European Union, the company plans to expand its marketing efforts in Europe. Premia Spine will also sponsor a US FDA study on patients who had the device implanted. The TOPS System originated from Impliant and has been perfected with an investment of over $50 million. The company is based in Ramat Poleg, near Netanya.
Customers
